Aim: Enterococci
are found in human flora and have quite low virulence. However, enterococci
cause nosocomial and community acquired infections, and in recent years there
has been an increase in antibiotic resistance rates in these infections. The
aim of this study was to evaluate the antibiotic susceptibility of Enterococcus faecalis and Enterococcus faecium, the most
frequently isolated enterococcal species.
Material and Method: In
our study, we evaluated 727 enterococcus strains obtained from various clinical
specimens that was accepted in medical microbiology laboratory from 2012 to
2016. Species
identification and antibiotic susceptibility tests were performed using
conventional methods and VITEK®-2
(BioMérieux, France) automated identification analyzer.
Results: In this study, 450 (61.9%) E. faecalis and 277 (38.1%) E. faecium were detected from 727 enterococci strains isolated. Gender distribution of patients with Enterococcus strains isolated; 387 (53.2%) women, 340 (46.8%) males. The distribution of the clinical specimens follows as 467 (64.2%) urine, 110 (15.1%) blood, 77 (10.6%) gaita, 43 (5.9%) wound and 30 (4.1%) other specimens. Enterococci strains were most frequently isolated from urine specimens. All isolates of E. faecium and E. faecalis strains were susceptible to tigecycline.Vancomycin resistance rates were determined as 29.9% (80/268) in E.faecium isolates and 8.6% (37/432) in E. faecalis isolates.
Conclusion: Increasing resistance rates in enterococci limit the use of many antibiotics against these infections. We thought that each hospital's own surveillance programming, identification of enterococci at species level, doing antibiotic susceptibility testing, and application of treatment protocols according to these resistance patterns are effective in controlling enterococcal infections.
Amaç: Enterokoklar
insan florasında bulunurlar ve oldukça düşük virulansa sahiptirler. Ancak,
enterokoklar hastane ve toplum kaynaklı enfeksiyonlara neden olmakta ve son
yıllarda bu enfeksiyonlarda antibiyotik direnç oranlarında artış
gözlenmektedir. Bu çalışmada en sık izole edilen enterokok türleri olan Enterococcus faecalis ve Enterococcus faecium’un antibiyotik
duyarlılıklarının değerlendirilmesi amaçlanmıştır.
Gereç ve Yöntem: Çalışmamızda
2012 - 2016 yılları arasında Tıbbi Mikrobiyoloji Laboratuvarımıza gelen çeşitli
klinik örneklerden izole edilen 727 enterokok suşu değerlendirmeye alınmıştır.
Tür tanımlamaları ve antibiyotik duyarlılık testleri konvansiyonel metodlar ve VITEK®-2
(BioMérieux, Fransa) otomatize identifikasyon cihazı ile yapılmıştır.
Bulgular: Bu çalışmada izole edilen 727
enterokok suşunun 450’si (%61,9) E.
faecalis, 277’si (%38,1) E. faecium
olarak tanımlanmıştır. Enterokok suşlarının izole edildiği hastaların cinsiyet
dağılımı; 387 (%53,2) kadın, 340 (%46,8) erkektir. Klinik örneklerin dağılımı; 467 (%64.2) idrar, 110 (%15.1) kan, 77 (%10.6)
gaita, 43 (%5.9) yara ve 30 %(4.1) diğer örneklerdir. Enterokok suşları
en sık idrar örneklerinden izole edilmiştir. İzole edilen E. faecium ve E. faecalis suşlarının
tamamı tigesikline duyarlı olarak saptanmıştır. Vankomisin direnç oranı E. faecium izolatlarında %29,9 (80/268), E. faecalis izolatlarında %8,6 (37/432) olarak belirlenmiştir.
Sonuç: Enterokoklarda son zamanlarda giderek artan
direnç oranları bu enfeksiyonlara karşı birçok antibiyotiğin kullanımını
sınırlandırmaktadır. Her hastanenin kendi sürveyans programını oluşturarak
enterokokların tür düzeyinde tanımlanması, antibiyogram duyarlılık testlerini yapılması
ve tedavi protokollerinin bu direnç paternlerine göre uygulanmasının enterokok
enfeksiyonlarının kontrol altına alınmasında etkili olacağı kanaatindeyiz.
Primary Language | Turkish |
---|---|
Subjects | Health Care Administration |
Journal Section | Original Article |
Authors | |
Publication Date | April 5, 2018 |
Published in Issue | Year 2018 Volume: 1 Issue: 1 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.